Labeler
Upsher-Smith Laboratories, LLC NDC Codes
Upsher-Smith Laboratories, LLC lists 221 finished drug products in the FDA NDC Directory under NDC labeler codes 0245, 0832, 24979, 80789.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Fluphenazine Hydrochloride, Zestril, Kymbee, Deflazacort, Tadalafil, Dicyclomine Hydrochloride, Torpenz, Isotretinoin, Naprelan, Tenormin, Naproxen Sodium, Galantamine, Pitavastatin, Diltiazem Hydrochloride, Fluvoxamine Maleate
- Active ingredients
- Deflazacort, Fluphenazine hydrochloride, Naproxen sodium, Potassium chloride, Lisinopril, Tadalafil, Dicyclomine hydrochloride, Everolimus, Isotretinoin, Brimonidine tartrate, Atenolol, Galantamine hydrobromide
- NDC labeler codes
- 0245, 0832, 24979, 80789
- Strengths (from the 100 most recently listed products)
- Potassium chloride 750 mg/1; Naproxen sodium 375 mg/1; Naproxen sodium 500 mg/1; Naproxen sodium 750 mg/1; Potassium chloride 600 mg/1; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Bupropion hydrochloride 450 mg/1; Dicyclomine hydrochloride 20 mg/1; Dicyclomine hydrochloride 10 mg/1; Fluphenazine hydrochloride 1 mg/1; Fluphenazine hydrochloride 5 mg/1; Fluphenazine hydrochloride 10 mg/1; Fluphenazine hydrochloride 2.5 mg/1; Deflazacort 22.75 mg/mL; Fluvoxamine maleate 150 mg/1; Fluvoxamine maleate 100 mg/1; Cyclosporine .5 mg/mL
- Dosage forms
- Tablet, Tablet, Film coated, Tablet, Film coated, Extended release, Tablet, Extended release, Capsule, Extended release, Capsule, Capsule, Delayed release, Capsule, Liquid filled, Solution/ drops, Suspension, Emulsion, Injection, Solution, Solution, Tablet, Delayed release, Powder, For suspension, For solution
- Routes
- Oral, Ophthalmic, Subcutaneous, Auricular (Otic)
- Drug classes (FDA established)
- Corticosteroid, Phenothiazine, Kinase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Osmotic Laxative, Potassium Salt, Angiotensin Converting Enzyme Inhibitor, beta-Adrenergic Blocker, Phosphodiesterase 5 Inhibitor, Anticholinergic, mTOR Inhibitor Immunosuppressant, Retinoid, Serotonin Reuptake Inhibitor, alpha-Adrenergic Agonist, Cholinesterase Inhibitor, HMG-CoA Reductase Inhibitor, Calcium Channel Blocker, Mood Stabilizer, Fluoroquinolone Antibacterial, Aromatase Inhibitor, Anti-epileptic Agent, Aminoketone, Proton Pump Inhibitor, Antimetabolite Immunosuppressant, Calcineurin Inhibitor Immunosuppressant, Histamine-2 Receptor Antagonist, Aminosalicylate, Melatonin Receptor Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 138 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| bupropion hydrochloride | Bupropion hydrochloride 450 mg/1 | Tablet, Film coated, Extended releaseOral | 24979-248 | 24979-0248-06 | — |
| Topiramate | Topiramate 15 mg/1 | CapsuleOral | 24979-210 | 24979-0210-04 | — |
| Topiramate | Topiramate 25 mg/1 | CapsuleOral | 24979-211 | 24979-0211-04 | — |
| Pitavastatinpitavastatin calcium | Pitavastatin calcium 1 mg/1 | TabletOral | 0832-6048 | 00832-6048-90 | — |
| Pitavastatinpitavastatin calcium | Pitavastatin calcium 2 mg/1 | TabletOral | 0832-6049 | 00832-6049-90 | — |
| Pitavastatinpitavastatin calcium | Pitavastatin calcium 4 mg/1 | TabletOral | 0832-6050 | 00832-6050-90 | — |
| Dicyclomine Hydrochloride | Dicyclomine hydrochloride 20 mg/1 | TabletOral | 24979-200 | 24979-0200-0124979-0200-0224979-0200-03 | — |
| Vigadronevigabatrin | Vigabatrin 500 mg/1 | TabletOral | 0245-6001 | 00245-6001-11 | — |
| Famotidine | Famotidine 40 mg/5mL | Powder, For suspensionOral | 0832-6045 | 00832-6045-1000832-6045-1500832-6045-50 | — |
| Mesalamine | Mesalamine .375 g/1 | Capsule, Extended releaseOral | 0832-6056 | 00832-6056-12 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 60 mg/1 | Capsule, Extended releaseOral | 24979-181 | 24979-0181-01 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 90 mg/1 | Capsule, Extended releaseOral | 24979-182 | 24979-0182-01 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | 24979-183 | 24979-0183-01 | — |
| Potassium Chloride Extended-Releasepotassium chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | 24979-231 | 24979-0231-0124979-0231-0224979-0231-03 | — |
| Potassium Chloride Extended-Releasepotassium chloride | Potassium chloride 1500 mg/1 | Tablet, Extended releaseOral | 24979-232 | 24979-0232-0124979-0232-02 | — |
| Dicyclomine hydrochloride | Dicyclomine hydrochloride 10 mg/1 | CapsuleOral | 0832-6053 | 00832-6053-1000832-6053-11 | — |
| Dicyclomine Hydrochloride | Dicyclomine hydrochloride 10 mg/1 | CapsuleOral | 24979-201 | 24979-0201-0124979-0201-03 | — |
| Brimonidine Tartrate and Timolol Maleate | Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 0832-1425 | 00832-1425-0500832-1425-1000832-1425-15 | — |
| Dexlansoprazole delayed releasedexlansoprazole | Dexlansoprazole 30 mg/1 | Capsule, Delayed releaseOral | 24979-001 | 24979-0001-0624979-0001-07 | — |
| Dexlansoprazole delayed releasedexlansoprazole | Dexlansoprazole 60 mg/1 | Capsule, Delayed releaseOral | 24979-002 | 24979-0002-0624979-0002-07 | — |
| sorafenib | Sorafenib 200 mg/1 | Tablet, Film coatedOral | 24979-715 | 24979-0715-0424979-0715-44 | — |
| Dicyclomine hydrochloride | Dicyclomine hydrochloride 20 mg/1 | TabletOral | 0832-6052 | 00832-6052-11 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 1 mg/1 | Tablet, Film coatedOral | 0832-6003 | — | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 0832-6005 | 00832-6005-11 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 0832-6006 | 00832-6006-11 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | 0832-6004 | 00832-6004-11 | — |
| Fluoxetine hydrochloride | Fluoxetine hydrochloride 20 mg/5mL | For solutionOral | 0832-6032 | 00832-6032-12 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 1 mg/1 | Tablet, Film coatedOral | 24979-136 | 24979-0136-01 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | 24979-137 | 24979-0137-01 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 24979-138 | 24979-0138-01 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 24979-139 | 24979-0139-01 | — |
| mycophenolic acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | 24979-160 | 24979-0160-44 | — |
| mycophenolic acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | 24979-161 | 24979-0161-44 | — |
| Torpenzeverolimus | Everolimus 10 mg/1 | TabletOral | 0245-0825 | 00245-0825-0400245-0825-30 | — |
| Torpenzeverolimus | Everolimus 2.5 mg/1 | TabletOral | 0245-0822 | 00245-0822-0400245-0822-30 | — |
| Torpenzeverolimus | Everolimus 5 mg/1 | TabletOral | 0245-0823 | 00245-0823-0400245-0823-30 | — |
| Torpenzeverolimus | Everolimus 7.5 mg/1 | TabletOral | 0245-0824 | 00245-0824-0400245-0824-30 | — |
| Isotretinoin | Isotretinoin 10 mg/1 | Capsule, Liquid filledOral | 0245-0570 | 00245-0570-01 | — |
| Isotretinoin | Isotretinoin 20 mg/1 | Capsule, Liquid filledOral | 0245-0571 | 00245-0571-01 | — |
| Isotretinoin | Isotretinoin 30 mg/1 | Capsule, Liquid filledOral | 0245-0573 | 00245-0573-01 | — |
| Carbamazepine | Carbamazepine 100 mg/1 | Tablet, Extended releaseOral | 0832-6022 | 00832-6022-11 | — |
| Carbamazepincarbamazepine | Carbamazepine 200 mg/1 | Tablet, Extended releaseOral | 0832-6023 | 00832-6023-11 | — |
| Carbamazepine | Carbamazepine 400 mg/1 | Tablet, Extended releaseOral | 0832-6024 | 00832-6024-11 | — |
| Isotretinoin | Isotretinoin 40 mg/1 | Capsule, Liquid filledOral | 0245-0575 | 00245-0575-01 | — |
| Moxifloxacin Hydrochloride | Moxifloxacin hydrochloride 5 mg/mL | SolutionOphthalmic | 0832-1410 | 00832-1410-03 | — |
| dimethyl fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | 24979-127 | 24979-0127-0224979-0127-21 | — |
| dimethyl fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | 24979-128 | 24979-0128-0224979-0128-04 | — |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | 0832-1250 | 00832-1250-1100832-1250-30 | — |
| Terbutaline Sulfate | Terbutaline sulfate 2.5 mg/1 | TabletOral | 24979-132 | 24979-0132-0124979-0132-03 | — |
| Terbutaline Sulfate | Terbutaline sulfate 5 mg/1 | TabletOral | 24979-133 | 24979-0133-0124979-0133-03 | — |
Upsher-Smith Laboratories, LLC: common questions
- What is Upsher-Smith Laboratories, LLC's NDC labeler code?
- 0245, 0832, 24979, 80789. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Upsher-Smith Laboratories, LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.